ION expands ETF trading capabilities with Tradeweb integration
Tilray Inc (TLRY) stock reached a 52-week high of 7.82 USD, marking a notable point for the company amid a challenging year. Despite this recent achievement, Tilray’s stock has experienced a significant decline, with a 1-year total return of -41.61%. InvestingPro data reveals a remarkable 92.19% price surge over the past six months, highlighting the stock’s extreme volatility with a beta of 2.1. This fluctuation highlights the volatile nature of the cannabis sector, where Tilray operates, and underscores the broader market dynamics affecting the company’s stock performance over the past year. The recent peak may signal a potential turnaround or a temporary uptick in investor sentiment. According to InvestingPro, analysts predict Tilray will be profitable this year with an EPS forecast of $0.17, though current valuation appears stretched compared to its Fair Value. Discover 12 more exclusive ProTips and comprehensive analysis in Tilray’s Pro Research Report, one of 1,400+ deep-dive reports that transform complex Wall Street data into actionable intelligence.
In other recent news, Tilray Brands Inc. reported its first-quarter fiscal year 2026 earnings, showcasing a net revenue of $210 million, marking a 5% increase compared to the previous year. The company achieved a net income of $1.5 million, a significant improvement from the net loss of $34.7 million recorded the previous year. This revenue figure exceeded forecasts by 2.4%, though the earnings per share remained at $0, below the forecasted -$0.04. Additionally, Tilray announced a 1-for-10 reverse stock split, which will take effect on December 1. This move will reduce the company’s outstanding shares from approximately 1.16 billion to 116 million. In another development, Tilray Medical plans to expand its operations into Panama through a joint venture with Top Tech Global Inc. The newly formed Solana Life Group has secured a medical cannabis license, allowing for cultivation, manufacturing, and distribution in Panama. These recent developments indicate strategic moves by Tilray to strengthen its financial position and expand its market presence.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.